Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
bill gates
bio
biontech
biotech
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
crispr
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
dyne therapeutics
editas medicine
eli lilly
escape bio
escient pharmaceuticals
europe blog main
europe top stories
finch therapeutics
What
company’s
2
×
debut
2
×
acquisitions
believe
biggest
bio
biotech
build
built
buy
ceo
concerns
crispr
daniel
dispute
drop
drops
drug
dyne’s
editas
editing
far
gene
gilead
hours
ipo’s
legally
microbiome
moves
nearly
openly
outfit
o’day
patent
percent
pipeline
plummeted
public
read
roundup
Language
unset
Current search:
debut
×
company’s
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute
